Designed for Simplicity. Engineered for Control. A new generation of pelvic neuromodulation - simplified. PosStim® has been designed to remove the complexity traditionally associated with neuromodulation systems. Compact, intuitive, and fully integrated, it enables a streamlined implantation and a seamless patient experience. Its miniaturized design allows placement through a minimal approach behind the pubic symphysis, ensuring stability without risk of rotation. The system is optimized for the GNS procedure, making neuromodulation accessible, reproducible, and independent of external technical support. The device is rechargeable via inductive charging, using a dedicated wearable belt designed for everyday life. A single integrated system combines both control and charging functions - eliminating the need for multiple external devices. With long battery life and a fully pre-connected electrode-generator system, PosStim® allows efficient handling in the operating room and reliable long-term performance.

The PosStim System®

Designed specifically for the GNS Procedure™

A fully integrated neuromodulation platform combining implantable stimulation with intuitive control and simplified clinical workflows.

  • Implantable Neurostimulator – Compact, minimally invasive device designed for ease of implantation and patient confort.
  • Streamlined Control Remore – Intuitive handheld remote for easy programming, adjustment, and self-monitoring of therapy.
  • Simplified Clinical Workflows  – Enables efficient in-office procedures and consistent therapeutic delivery.
NeuroGyn is the inventor of both the GNS Procedure®
and the PosStim® System - combining procedural 
innovation with proprietary technology.

The Future of Pelvic Neuromodulation
  1. Problem – Pelvic disorders affect millions – yet current therapies remain complex, expansive, and underutilized.
  2. Limitation today – Sacral neuromodulation is effective, but rarely performed in gynecology due to surgical complexity and workflow constraints.
  3. Our solution – PosStim introduces a new paradigm: simple, ambulatory neuromodulation, accessible to every gynecologist.
  4. Massive cost reduction – no surgical trial, implantation in ambulatory sector.

 

A long-term collaboration. A mature technology.

Our collaboration with imec began in 2021, with a clear ambition: to develop a new generation of implantable bioelectronic therapy for pelvic disorders. Following multiple development phases and iterative validation, the system design was frozen in 2025. Today, in 2026, the full R&D cycle has been successfully completed — including the implantable neurostimulator, control system/charging platform. We are now entering the next phase: clinical validation in humans and industrial deployment.